Litcius/Paper detail

Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States

Rahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, Deepak L. Bhatt

2021Progress in Cardiovascular Diseases21 citationsDOI

Topics & Concepts

MedicineSemaglutideOverweightDrug approvalObesityPharmacologyInternal medicineEndocrinologyDiabetes mellitusType 2 diabetesLiraglutideDrugDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States | Litcius